Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. - Wikidata - wikimedia - TriplyDB

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.

http://www.wikidata.org/entity/Q36026810

about

Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade.Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells.Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways.Association between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) study Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.Intratubular renin-angiotensin system in hypertension Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats.Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury.Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease.Angiopoietin-1 gene therapy attenuates hypertension and target organ damage in nitric oxide synthase inhibited spontaneously hypertensive rats.Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation.Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys.Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice.Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions Plasma Soluble (Pro)renin Receptor Reflects Renal Damage Liver angiotensinogen is the primary source of renal angiotensin II.Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease Novel sandwich ELISA for human angiotensinogen Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat.Fetal programming of hypertension.Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney Pharmacological management of renal fibrotic disease.Important aspects of urine sampling for angiotensinogen measurement: time and preservation conditions in healthy individuals

P2860

Q28571965-B61AB031-A0A9-499D-A646-123EA91CEE24 Q33677156-92A7C834-D335-4167-9CFB-84099EFE44A9 Q33714897-99F66982-7A55-4A45-A626-E57D76E65F79 Q33716378-627C5FEE-54C3-44FB-8E3E-A4458C94CC2A Q33887622-D73284AB-9519-43DB-8C60-1DDF6C0E9E31 Q34203622-B7DB23AD-01FD-4DE6-B7EE-9A7401958D62 Q34211709-D0235EAD-3E96-4949-91DD-C388895468FC Q34283151-9665526D-D490-4BBE-86F7-382DDFE8187F Q34460012-4A600E74-AB86-4B93-B715-BD0197111C75 Q34642815-C49A4F14-BD9F-4B78-82D8-E6E155ED1F68 Q34647857-B037BF4B-FD8D-4C00-BB52-67ED8859853A Q34715015-38C8594F-CDEF-43B0-96D8-5D1E53337DFC Q34777649-41F8633B-AFCA-46F3-A535-BC070DEAECEB Q35025450-7CBD340A-64B9-4ABE-9582-28284DFF6909 Q35161497-1965721B-A8CA-4EEF-9271-CABF757445A8 Q35176118-2A63403D-8921-4168-9C48-5DF77EB4C406 Q35227691-BAA7E1C9-8CEC-497C-9F99-EDB238589C39 Q35245800-056AB1F2-A320-4BDC-91C2-F8501A04E8C0 Q35566707-51292146-2DA2-4548-8022-1363BD2A146C Q35663915-3B9DB8DF-C116-48AC-8AD3-6FAD9AD26677 Q35745326-6E7D3EAA-9212-4868-B66C-32F1C37B310C Q35842921-778DC9C3-8768-4FAF-B166-CF81C930042C Q35913007-98BC89D6-0983-4D3E-961A-B874AC30D122 Q35934092-A8856651-E35B-4636-B44C-3E4E21D12C5C Q35995685-AAC12298-5EAC-4489-9725-3CF5A54185AC Q36023483-5869398B-7313-466A-A9B9-891492BD111A Q36026798-4C432C77-5C05-491F-BCDE-F3BCD6FE79CA Q36030615-5CBAA39C-DA63-4F4E-AA93-EBD950D7744B Q36050931-B6DFF6A2-B4F9-4C75-92D9-6EBCF34F03C4 Q36079520-2D677372-2B81-4856-94EF-27225CB15C1B Q36116868-70CBCFD9-AFC1-492B-AF08-BEF6BDFB2436 Q36129853-529862DA-7324-4450-99D3-D21071A6ED1B Q36168729-96CFA153-4FD8-47FC-AFE1-02395C929A19 Q36168835-2DA84F6A-77E6-4CF2-A875-13B6CAF59AFC Q36236725-DDEC157F-5DFD-4417-B16B-A0BF27B39AF6 Q36274816-F6A23002-3E34-4DC9-B930-A02B183A2AE6 Q36341270-F2E0141A-ABBA-44FE-984F-507ED42A7890 Q36405827-3E00C598-77EA-449D-8A86-3575D2090A23 Q36407348-C11418B1-9FA3-4B34-9CF3-5475D497C912 Q36421164-8FDFD760-24A5-43A0-AC1D-FE71E5DD1CA2

P2860

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.

http://www.wikidata.org/entity/Q36026810

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@ast

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@en

type

label

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@ast

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@en

prefLabel

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@ast

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@en

P1433

Q36026810-0B56B857-F6F6-4FC4-A263-9F180F896E0D

P1476

Q36026810-69AA4F2A-BF95-45FD-8D43-10992E86D501

P2093

Q36026810-248C94C5-0255-4FAB-8E48-D17E4B582F84

Q36026810-261BC9B6-2DCB-4DB4-BDA1-BF8930AF949D

Q36026810-4E88E195-7899-42EC-8CA1-2B2C74A5E69D

Q36026810-64F8A2B1-69D5-4C0C-8F8E-A2A6BAA939E7

P2860

Q36026810-0FDD104B-7479-4FB6-82FD-8D8675F5912B

Q36026810-185D9E41-FFDB-455E-B063-537EBFDC4DB6

Q36026810-19A2AE5D-9AE7-4341-9144-33704D20533D

Q36026810-3B90743B-65E2-4E78-BD3B-3646EBB78960

Q36026810-4264CE85-BE95-4263-BBD7-8A6863A5E1D0

Q36026810-511352F2-3C91-4225-828C-544722C90800

Q36026810-578EFFB2-E6AA-4C1C-B04A-844264D4DA1E

Q36026810-6655A6ED-6CE1-490B-9662-9C4A3A86B04D

Q36026810-7D7C0A47-9275-4354-9AA7-4CD1D00BC07C

Q36026810-880B0DC8-8873-486B-9A0E-2641E91282C7

P304

Q36026810-1908E9DB-00A4-46AA-BDC7-B512377C25C3

P31

Q36026810-436D61ED-75A2-41BD-BE40-6295F2D4E01F

P356

Q36026810-AFBBCE32-1527-4792-92AF-C5D968AB6AF1

P433

Q36026810-AC32F561-9FE0-45EB-B112-1276B1539DE1

P478

Q36026810-A012A6AE-CBA9-4E13-ACCB-F78B7542AE97

P577

Q36026810-0992917C-9DC3-4F49-BD69-6426EA2D6E6B

P698

Q36026810-8CEF3579-34EA-411A-B05C-26737A9519DA

P932

Q36026810-B290B4C1-B4BB-4305-9C2C-EB2A7CBA6AC7

P356

P1433

Journal of the American Society of Nephrology

P1476

Enhanced intrarenal angiotensi ...... ontaneously hypertensive rats.

@en

P2093

Akira Nishiyama

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kobori

http://www.w3.org/2001/XMLSchema#string

Yuki Suzaki

http://www.w3.org/2001/XMLSchema#string

Yuri Ozawa

http://www.w3.org/2001/XMLSchema#string

P2860

Kinetics of the human renin and human substrate reaction

Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model.

Expression of alpha-smooth muscle actin in the developing kidney vasculature.

Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition.

Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats

Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle

Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet.

Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension

P304

2073-2080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2004080676

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15888567

http://www.w3.org/2001/XMLSchema#string

P932

2001292

http://www.w3.org/2001/XMLSchema#string